Globeflex Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,395
Closed -$73.3K 477
2022
Q4
$73.3K Hold
2,395
0.01% 424
2022
Q3
$59K Buy
+2,395
New +$79K 0.01% 437
2020
Q2
Sell
-24,340
Closed -$216K 518
2020
Q1
$216K Hold
24,340
0.07% 348
2019
Q4
$440K Sell
24,340
-12,554
-34% -$208K 0.08% 335
2019
Q3
$551K Hold
36,894
0.12% 278
2019
Q2
$885K Sell
36,894
-46
-0.1% -$1.36K 0.18% 182
2019
Q1
$1.37M Hold
36,940
0.29% 104
2018
Q4
$1.04M Buy
36,940
+3
+0% +$95 0.25% 130
2018
Q3
$1.46M Sell
36,937
-547
-1% -$23.9K 0.29% 111
2018
Q2
$1.66M Sell
37,484
-5,865
-14% -$292K 0.34% 83
2018
Q1
$2.11M Buy
43,349
+33,738
+351% +$1.69M 0.45% 48
2017
Q4
$481K Sell
9,611
-4,745
-33% -$249K 0.13% 239
2017
Q3
$727K Sell
14,356
-119,432
-89% -$5.63M 0.21% 184
2017
Q2
$5.07M Sell
133,788
-13,550
-9% -$534K 1.25% 4
2017
Q1
$5.67M Hold
147,338
1.34% 4
2016
Q4
$3.25M Sell
147,338
-755
-0.5% -$15.5K 0.81% 7
2016
Q3
$2.37M Buy
+148,093
New +$1.69M 0.59% 19

Other funds holding CC

Globeflex Capital's CC Position: Q1 2023 in Review

Globeflex Capital sold out of Chemours (CC) in Q1 2023, closing a stake of 2,395 shares — an estimated $73.3K sold.

Globeflex Capital first reported a position in CC in Q3 2016 and held it in 17 quarters. The position peaked at $5.67M in Q1 2017. 487 funds tracked by Wall St. Rank hold CC as of Q1 2023.

  • Globeflex Capital reported no remaining Chemours position as of Q1 2023 after selling out during the quarter.
  • Globeflex Capital sold 2,395 Chemours shares in Q1 2023, an estimated $73.3K.
  • Globeflex Capital first reported a position in Chemours in Q3 2016 and held it in 17 quarters.
  • Globeflex Capital's Chemours position peaked at $5.67M in Q1 2017.
  • 487 funds tracked by Wall St. Rank held Chemours as of Q1 2023.

Based on Globeflex Capital's 13F filing for Q1 2023, filed 12 May 2023.